Stroke in chronic kidney disease: prevention and management

Clinical Journal of the American Society of Nephrology : CJASN
Raymond R Townsend

Abstract

The incidence of stroke is elevated among individuals with kidney disease. Traditional risk factors seem to account for much but not all of this excess risk. Blood pressure control is the most important aspect of stroke prevention. Multiple classes of antihypertensive agents, including diuretics, calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers, have reduced stroke risk. Some physiologic and clinical evidence suggests that angiotensin II receptor blockers may offer superior benefit to that of angiotensin-converting enzyme inhibitors for the same level of blood pressure control; however, few head-to-head trials have compared these two agent classes directly using stroke as an outcome.

References

Mar 1, 1997·Stroke; a Journal of Cerebral Circulation·S G WannametheeI J Perry
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Sep 6, 2001·Stroke; a Journal of Cerebral Circulation·Y M RuigrokG J Rinkel
Jan 17, 2003·Annals of Internal Medicine·Marcello TonelliUNKNOWN Cholesterol and Recurrent Events (CARE) Trial Investigators
Feb 14, 2003·The New England Journal of Medicine·Lindon M H WingUNKNOWN Second Australian National Blood Pressure Study Group
Apr 5, 2003·Stroke; a Journal of Cerebral Circulation·Harold P AdamsUNKNOWN Stroke Council of the American Stroke Association
Apr 16, 2003·Kidney International. Supplement·Colin Baigent, Martin Landry
Nov 15, 2003·Lancet·Fiona Turnbull, UNKNOWN Blood Pressure Lowering Treatment Trialists' Collaboration
Feb 12, 2004·Kidney International·Aud HøieggenUNKNOWN LIFE Study Group
Jan 25, 2005·Lancet Neurology·Gabriel J E Rinkel
Feb 8, 2006·Annals of Internal Medicine·Mahboob RahmanUNKNOWN ALLHAT Collaborative Research Group
May 9, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN KDOQI, UNKNOWN National Kidney Foundation
Nov 17, 2006·The New England Journal of Medicine·Ajay K SinghUNKNOWN CHOIR Investigators
Nov 17, 2006·The New England Journal of Medicine·Giuseppe Remuzzi, Julie R Ingelfinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.